{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-010566","form_type":"8-K","ticker":"NATR","cik":"0000275053","company_name":"NATURES SUNSHINE PRODUCTS INC","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.514617+00:00","generated_at":"2026-06-04T23:30:44.853819+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nature's Sunshine Q4 net income triples to $9.0M; full-year 2023 adjusted EBITDA up 26%","bullets":["Q4 net sales $108.9M, up 6% YoY; North America sales up 12.8%. GAAP EPS $0.46 vs $0.10.","Full year 2023 net sales $445.3M (+5.5%); GAAP net income $15.1M vs loss $0.4M in 2022.","Q4 adjusted EBITDA $9.7M (+21%); full-year adjusted EBITDA $40.4M (+26%).","FY 2024 outlook: net sales $455-$480M, adjusted EBITDA $42-$48M.","No outstanding debt, cash $82.4M; repurchased 424K shares for $6.4M in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-010566","json":"https://secwatch.observer/filing/0001628280-24-010566.json","markdown":"https://secwatch.observer/filing/0001628280-24-010566.md","text":"https://secwatch.observer/filing/0001628280-24-010566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/275053/000162828024010566/0001628280-24-010566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/275053/000162828024010566/natr-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:30:44.853819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df875f042d791b3ab76f21133ea90e717f79d7fb","claim":"NATURES SUNSHINE PRODUCTS INC reported the fourth quarter and full year ended December 31, 2023 results: revenue $108.9 million, net income $9.0 million, or $0.46 per diluted share, EPS $0.46 per diluted share.","evidence_excerpt":"financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights vs. Same Year-Ago Quarter • Net sales were up 6.0% to $108.9 million compared to $102.7 million (up 5.6% in constant currency). • GAAP net income attributable to common shareholders up significantly to $9.0 million, or $0.46 per diluted share,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/275053/000162828024010566/0001628280-24-010566-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"$108.9 million"},{"label":"Net income","value":"$9.0 million, or $0.46 per diluted share"},{"label":"EPS","value":"$0.46 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}